Mathias Haag
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(DE)Swedish Environmental Protection Agency(SE)University of Tübingen(DE)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Hepatitis B Virus Studies, Mitochondrial Function and Pathology, Hepatitis C virus research, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study(2016)383 cited
- → The genetic interactome of prohibitins: coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondria(2009)294 cited
- → Intramitochondrial Transport of Phosphatidic Acid in Yeast by a Lipid Transfer Protein(2012)230 cited
- → TRIAP1/PRELI Complexes Prevent Apoptosis by Mediating Intramitochondrial Transport of Phosphatidic Acid(2013)220 cited
- → First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B(2016)215 cited
- → DNAJC19, a Mitochondrial Cochaperone Associated with Cardiomyopathy, Forms a Complex with Prohibitins to Regulate Cardiolipin Remodeling(2014)203 cited